◆ NeutralADMA
ADMA DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire Inc.·
A class action lawsuit has been filed against ADMA Biologics for allegedly making false statements regarding revenue growth, engaging in channel stuffing, and failing to disclose related party transactions. Following a critical report by Culper Research on March 24, 2026, ADMA's stock declined over 16%, and subsequently fell another 13% after a Cantor Fitzgerald downgrade. Investors with substantial losses between August 9, 2024 and March 25, 2026 can seek appointment as lead plaintiff by August 10, 2026.
Read Full Article at GlobeNewswire Inc. →